沙利度胺靶向CRBN通过抑制NF-κB通路减轻青光眼引流术后纤维化
本研究在大鼠青光眼引流手术(GDS)模型和TGF-β2诱导的细胞模型中,探讨CRBN及其配体沙利度胺(THD)对术后纤维化的作用。结果显示GDS后Tenon囊组织中CRBN表达上调,THD可抑制CRBN表达、剂量依赖性抑制TGF-β2诱导的细胞增殖与转分化,并在体内延长滤过泡存活、抑制α-SMA表达。机制上THD抑制P65磷酸化从而阻断NF-κB通路活化,提示CRBN是减轻GDS后纤维化的新干预靶点。
要点
- GDS后Tenon囊组织CRBN表达上调,THD可显著减弱CRBN表达。
- THD剂量依赖性抑制TGF-β2诱导的细胞增殖及人Tenon成纤维细胞转分化。
- THD局部应用延长大鼠滤过泡存活并抑制α-SMA表达,机制涉及抑制NF-κB通路。
核心结论
- CRBN是调控GDS后纤维化的关键蛋白,THD通过靶向CRBN并抑制NF-κB通路发挥抗纤维化作用。
- CRBN作为减轻GDS后纤维形成的新干预靶点被提出。
研究设计与样本
- 研究采用大鼠GDS模型和TGF-β2诱导的细胞模型。
- 通过免疫荧光检测Tenon囊组织CRBN表达,术后监测滤过泡存活。
- 采用Western blotting和免疫组化检测α-SMA、FN和PCNA蛋白水平。
- 通过检测P65和p-P65水平评估NF-κB通路活化。
主要发现
- GDS后Tenon囊组织中CRBN表达上调。
- THD处理显著减弱CRBN表达。
- THD剂量依赖性抑制TGF-β2诱导的细胞增殖。
- Western blotting证实THD抑制TGF-β2诱导的人Tenon成纤维细胞转分化和增殖。
- 体内局部应用THD延长滤过泡存活并抑制α-SMA表达,机制上THD抑制P65磷酸化从而阻止NF-κB通路活化。
临床怎么用
- 局部应用THD可能通过靶向CRBN抑制NF-κB通路来延长GDS后滤过泡存活。
- CRBN可作为减轻GDS后纤维化的潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Fibrosis after glaucoma drainage surgery (GDS) is the main factor behind glaucoma surgery failures. Previous studies showed that cereblon (CRBN) protein is involved in tissue differentiation, although its role in glaucoma remains unknown. Herein we explored the role of CRBN and its ligand thalidomide (THD) in fibrosis after GDS. METHODS: Using a rat GDS model and TGF-β2-induced cell model, we investigated the functions of CRBN and THD. CRBN expression in Tenon capsule tissue was detected using immunofluorescence. Filtering bleb survival was monitored after surgery. Protein levels of α‑smooth muscle actin (SMA), fibronectin (FN), and proliferating cell nuclear antigen (PCNA) were measured by Western blotting and immunohistochemistry. Activation of the nuclear factor (NF)‑κB pathway was evaluated via detecting P65 and p‑P65 levels. RESULTS: CRBN expression was upregulated in Tenon capsule tissue after GDS. THD treatment significantly attenuated CRBN expression. Moreover, THD dose-dependently inhibited TGF-β2-induced cell proliferation. Western blotting confirmed that THD suppresses TGF-β2-induced transdifferentiation and proliferation of human Tenon fibroblasts. In vivo, topical THD application prolonged filtering bleb survival and restrained α-SMA expression. Mechanistically, THD inhibited P65 phosphorylation, thereby preventing the activation of the NF-κB pathway. CONCLUSIONS: CRBN is a key protein regulating fibrosis following GDS. THD exerts anti-fibrotic effects by targeting CRBN and inhibiting the NF-κB pathway. These findings unveil a novel intervention target, CRBN, for attenuating fibrogenesis after GDS.
引用
- Wang L, Li H, Xiong L, et al. Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition. Invest Ophthalmol Vis Sci. 2026. PMID: 41860320. doi:10.1167/iovs.67.3.48
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。